Artificial intelligence-based quantification of residual cancer burden to evaluate the impact of neoadjuvant therapy in resected pancreatic cancer in the PREOPANC randomised trial

Pancreatology(2023)

Cited 0|Views32
No score
Key words
pancreatic cancer,residual cancer burden,neoadjuvant therapy,randomised trial,intelligence-based
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined